Cargando…
Serum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemia
The evaluation of minimal residual disease (MRD) in acute leukemia (AL) is currently recognized as a potential critical tool to assess the response and relapse rate of treatments. The present study investigated serum peptides from patients with AL to identify biomarkers that would be useful in provi...
Autores principales: | SONG, WEI, WANG, NA, LI, WEI, WANG, GUANJUN, HU, JIFAN, HE, KUN, LI, YAN, MENG, YING, CHEN, NAIFEI, WANG, SHAOXIN, HU, LINGYUN, XU, BIN, WANG, JIE, LI, AILING, CUI, JIUWEI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813581/ https://www.ncbi.nlm.nih.gov/pubmed/24179540 http://dx.doi.org/10.3892/ol.2013.1574 |
Ejemplares similares
-
Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer
por: Song, Wei, et al.
Publicado: (2014) -
Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
por: Bai, Ju, et al.
Publicado: (2014) -
Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling
por: Bai, Ju, et al.
Publicado: (2013) -
Correction to: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia
por: Bai, Ju, et al.
Publicado: (2020) -
Nerves in the Tumor Microenvironment: Origin and Effects
por: Wang, Wenjun, et al.
Publicado: (2020)